BEDFORD, Mass.--(BUSINESS WIRE)--Apr. 24, 2018--
Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics
medicines company specializing in therapeutics based on its proprietary hyaluronic
acid ("HA") technology, today announced that its President
and Chief Executive Officer, Joseph Darling, will make a presentation at
the 2018 Deutsche Bank Health Care Conference on Tuesday, May 8, 2018 at
8:40 am ET. The conference is being held at the InterContinental Boston
Hotel in Boston, MA.
A live audio webcast of the presentation may be accessed via the “Investor
Relations” section of Anika’s website at www.anikatherapeutics.com.
An audio archive of the presentation also will be available on the
About Anika Therapeutics, Inc.
Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated orthopedic
medicines company based in Bedford, Massachusetts. Anika is committed to
improving the lives of patients with degenerative orthopedic diseases
and traumatic conditions with clinically meaningful therapies along the
continuum of care, from palliative pain management to regenerative
cartilage repair. The Company has over two decades of global expertise
developing, manufacturing, and commercializing more than 20 products
based on its proprietary hyaluronic
acid (HA) technology. Anika's orthopedic medicine portfolio includes ORTHOVISC®,
which alleviate pain and restore joint function by replenishing depleted
HA, and HYALOFAST,
a solid HA-based scaffold to aid cartilage repair and regeneration. For
more information about Anika, please visit www.anikatherapeutics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180424006542/en/
Source: Anika Therapeutics, Inc.
For Investor Inquiries:
Anika Therapeutics, Inc.
Chief Financial Officer
Pure Communications, Inc.